These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 9932414)

  • 21. Neuropathologic features of Parkinson's, Huntington's, and Alzheimer's diseases.
    Forno LS
    Ann N Y Acad Sci; 1992 May; 648():6-16. PubMed ID: 1386207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuronal filaments in Alzheimer's, Pick's, and Parkinson's diseases.
    Kahn J; Anderton BH; Gibb WR; Lees AJ; Wells FR; Marsden CD
    N Engl J Med; 1985 Aug; 313(8):520-1. PubMed ID: 4040609
    [No Abstract]   [Full Text] [Related]  

  • 23. Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia.
    Chan-Palay V
    J Comp Neurol; 1988 Jul; 273(4):543-57. PubMed ID: 2463283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parkinson's disease and Alzheimer's disease: new neurochemical parallels.
    Whitehouse PJ
    Mov Disord; 1989; 4 Suppl 1():S57-62. PubMed ID: 2786144
    [No Abstract]   [Full Text] [Related]  

  • 25. Resting-state networks in Alzheimer's disease and Parkinson's disease.
    Rektorova I
    Neurodegener Dis; 2014; 13(2-3):186-8. PubMed ID: 24008996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A modern hypothesis: The distinct pathologies of dementia associated with Parkinson's disease versus Alzheimer's disease.
    Farlow MR; Cummings J
    Dement Geriatr Cogn Disord; 2008; 25(4):301-8. PubMed ID: 18311077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parkinson's disease, motoneuron disease and Alzheimer's disease: origins and interrelationship.
    Calne DB; Eisen A
    Adv Neurol; 1990; 53():355-60. PubMed ID: 2239477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases.
    Selkoe DJ
    Nat Cell Biol; 2004 Nov; 6(11):1054-61. PubMed ID: 15516999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pathological study of the association between Lewy body disease and Alzheimer's disease.
    Gibb WR; Mountjoy CQ; Mann DM; Lees AJ
    J Neurol Neurosurg Psychiatry; 1989 Jun; 52(6):701-8. PubMed ID: 2545826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroimaging signature of neuropsychiatric disorders.
    Worbe Y
    Curr Opin Neurol; 2015 Aug; 28(4):358-64. PubMed ID: 26110796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can Alzheimer's type pathology influence the clinical phenotype of Parkinson's disease?
    Papapetropoulos S; Lieberman A; Gonzalez J; Mash DC
    Acta Neurol Scand; 2005 Jun; 111(6):353-9. PubMed ID: 15876335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concurrence of Alzheimer's disease, Parkinson's disease, diffuse Lewy body disease, and amyotrophic lateral sclerosis.
    Hedera P; Lerner AJ; Castellani R; Friedland RP
    J Neurol Sci; 1995 Feb; 128(2):219-24. PubMed ID: 7738598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part IX. A prospective cliniconeuropathologic study of Parkinson's features in Alzheimer's disease.
    Hulette C; Mirra S; Wilkinson W; Heyman A; Fillenbaum G; Clark C
    Neurology; 1995 Nov; 45(11):1991-5. PubMed ID: 7501147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Olfactory disorders in Alzheimer's disease and in Parkinson's disease. Review of the literature].
    Norès JM; Biacabe B; Bonfils P
    Ann Med Interne (Paris); 2000 Mar; 151(2):97-106. PubMed ID: 10855362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First signs of glaucoma injury occur in the brain. What has generally been considered an eye disease is actually related to conditions such as Alzheimer's and Parkinson's diseases.
    Duke Med Health News; 2010 May; 16(5):4-5. PubMed ID: 20518132
    [No Abstract]   [Full Text] [Related]  

  • 36. Tactile discrimination learning deficits in Alzheimer's and Parkinson's diseases.
    Freedman M; Oscar-Berman M
    Arch Neurol; 1987 Apr; 44(4):394-8. PubMed ID: 3827695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circadian alterations in patients with neurodegenerative diseases: Neuropathological basis of underlying network mechanisms.
    Fifel K; Videnovic A
    Neurobiol Dis; 2020 Oct; 144():105029. PubMed ID: 32736083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective delayed response deficits in Parkinson's and Alzheimer's disease.
    Freedman M; Oscar-Berman M
    Arch Neurol; 1986 Sep; 43(9):886-90. PubMed ID: 3741206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lewy bodies in Alzheimer's disease in which the primary lesion is a mutation in the amyloid precursor protein.
    Hardy J
    Neurosci Lett; 1994 Oct; 180(2):290-1. PubMed ID: 7700596
    [No Abstract]   [Full Text] [Related]  

  • 40. Commentary on "Neuropathologic evidence that the Lewy body variant of Alzheimer disease represents coexistence of Alzheimer disease and idiopathic Parkinson's disease (1998;57:39-46)".
    Jellinger KA
    J Neuropathol Exp Neurol; 1998 May; 57(5):467-8. PubMed ID: 9596417
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.